Real-world treatment patterns of OTX-101 ophthalmic solution, cyclosporine ophthalmic emulsion, and lifitegrast ophthalmic solution in patients with dry eye disease: a retrospective analysis

Abstract Background Dry eye disease (DED) is a disorder characterized by loss of tear film homeostasis that causes ocular surface inflammation and damage. The incidence of DED increases with age. Cyclosporine ophthalmic solution 0.09% (CEQUA®; OTX-101), cyclosporine ophthalmic emulsion 0.05% (Restas...

Повний опис

Бібліографічні деталі

Автори:	Paul Karpecki, Victoria Barghout, Brad Schenkel, Lynn Huynh, Anamika Khanal, Brittany Mitchell, Mihran Yenikomshian, Enrico Zanardo, Cynthia Matossian
Формат:	Artigo
Мова:	Inglês
Опубліковано:	BMC 2023-11-01
Серія:	BMC Ophthalmology
Предмети:	Cyclosporine A Discontinuation Keratoconjunctivitis sicca Persistence
Онлайн доступ:	https://doi.org/10.1186/s12886-023-03174-y
Теги:	Додати тег Немає тегів, Будьте першим, хто поставить тег для цього запису!